Neuropeptides in dental pulp: the silent protagonists.
Dental pulp is a soft mesenchymal tissue densely innervated by afferent (sensory) fibers, sympathetic fibers, and parasympathetic fibers. This complexity in pulp innervation has motivated numerous investigations regarding how these 3 major neuronal systems regulate pulp physiology and pathology. Most of this research is focused on neuropeptides and their role in regulating pulpal blood flow and the development of neurogenic inflammation. These neuropeptides include substance P, calcitonin gene-related peptide, neurokinin A, neuropeptide Y, and vasoactive intestinal polypeptide among others. The purpose of this article is to review recent advances in neuropeptide research on dental pulp, including their role in pulp physiology, their release in response to common dental procedures, and their plasticity in response to extensive pulp and dentin injuries. Special attention will be given to neuropeptide interactions with pulp and immune cells via receptors, including studies regarding receptor identification, characterization, mechanisms of action, and their effects in the development of neurogenic inflammation leading to pulp necrosis. Their role in the growth and expansion of periapical lesions will also be discussed. Because centrally released neuropeptides are involved in the development of dental pain, the pain mechanisms of the pulpodentin complex and the effectiveness of present and future pharmacologic therapies for the control of dental pain will be reviewed, including receptor antagonists currently under research. Finally, potential clinical therapies will be proposed, particularly aimed to manipulate neuropeptide expression or blocking their receptors, to modulate a variety of biologic mechanisms, which preliminary results have shown optimistic results.
Endodontics Department, School of Dentistry, Pontificia Universidad Javeriana, Bogotá, Colombia. javiercaviedes@cable.net.co
Javier
J
Caviedes-Bucheli
Hugo Roberto
HR
Muñoz
María Mercedes
MM
Azuero-Holguín
Esteban
E
Ulate
D016301:Alveolar Bone Loss / Q000503:physiopathology; D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000096:biosynthesis / Q000502:physiology; D003782:Dental Pulp / Q000098:blood supply / Q000294:innervation* / Q000378:metabolism*; D006801:Humans; D020078:Neurogenic Inflammation; D015288:Neurokinin A / Q000096:biosynthesis / Q000502:physiology; D009475:Neurons, Afferent / Q000502:physiology; D009478:Neuropeptide Y / Q000096:biosynthesis / Q000502:physiology; D009479:Neuropeptides / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D011671:Pulpitis / Q000503:physiopathology; D013373:Substance P / Q000096:biosynthesis / Q000502:physiology; D014098:Toothache / Q000188:drug therapy / Q000503:physiopathology*; D014660:Vasoactive Intestinal Peptide / Q000096:biosynthesis / Q000502:physiology
D009478:Neuropeptide Y; D009479:Neuropeptides; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D015288:Neurokinin A; D015740:Calcitonin Gene-Related Peptide